サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1356589

局所ドラッグデリバリーレポート：2030年までの動向、予測、競合分析

Topical Drug Delivery Report: Trends, Forecast and Competitive Analysis to 2030

出版日
発行
Lucintel
ページ情報
英文 150 Pages
納期
3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.46円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

局所ドラッグデリバリーレポート：2030年までの動向、予測、競合分析
出版日: 2023年09月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

局所ドラッグデリバリーの動向と予測

世界の局所ドラッグデリバリー市場は、2024年から2030年までのCAGRが8.5%で、2030年までに推定3,966億米ドルに達すると予想されています。この市場の主な促進要因は、皮膚関連疾患の頻度の増加、火傷関連傷害の発生率の増加、糖尿病の有病率の上昇です。世界の局所ドラッグデリバリー市場の将来は、在宅医療環境、病院・診療所、火傷センター市場にビジネスチャンスがあり、有望視されています。

局所ドラッグデリバリー市場の洞察

Lucintelは、異なる薬理学的化合物を送達する柔軟性と使いやすさから、半固形製剤が予測期間中に最も高い成長を遂げると予測しています。

在宅介護の現場では、手頃な価格で便利な局所ドラッグデリバリーサービスに対するニーズが高まっているため、今後も最大セグメントであり続けると思われます。

北米は、喫煙者の増加、自己投与薬の需要の高さ、主要製薬企業の存在により、予測期間中に最も高い成長が見込まれます。

本レポートでは、以下の11の主要な質問に回答している：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の局所ドラッグデリバリー市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の局所ドラッグデリバリー市場の動向（2018-2023）と予測（2024-2030）
  • 製品別の世界の局所ドラッグデリバリー市場
    • 半固形製剤
    • 液体製剤
    • 固形製剤
    • 経皮吸収製品
  • 投与経路別の世界の局所ドラッグデリバリー市場
    • 経皮ドラッグデリバリー
    • 点眼ドラッグデリバリー
    • 直腸ドラッグデリバリー
    • 膣内ドラッグデリバリー
    • 経鼻薬ドラッグデリバリー
  • 最終用途産業別の世界の局所ドラッグデリバリー市場
    • ホームケア設定
    • 病院とクリニック
    • バーンセンター
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の局所ドラッグデリバリー市場
  • 北米の局所ドラッグデリバリー市場
  • 欧州の局所ドラッグデリバリー市場
  • アジア太平洋の局所ドラッグデリバリー市場
  • その他地域局所ドラッグデリバリー市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 製品別の世界の局所ドラッグデリバリー市場の成長機会
    • 投与経路別の世界の局所ドラッグデリバリー市場の成長機会
    • 最終用途産業別の世界の局所ドラッグデリバリー市場の成長機会
    • 世界の局所ドラッグデリバリー市場地域の成長機会
  • 世界の局所ドラッグデリバリー市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の局所ドラッグデリバリー市場の能力拡大
    • 世界の局所ドラッグデリバリー市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Glenmark Pharmaceuticals
  • Galderma
  • Johnson & Johnson
  • GlaxoSmithkline
  • Bausch Health
  • Hisamitsu Pharmaceuticals
  • Cipla
  • Bayer
  • Viatris
  • 3M
目次

Topical Drug Delivery Trends and Forecast

The future of the global topical drug delivery market looks promising with opportunities in the home care settings, hospitals & clinics, and burn centers markets. The global topical drug delivery market is expected to reach an estimated $396.6 billion by 2030 with a CAGR of 8.5% from 2024 to 2030. The major drivers for this market are increasing frequency of skin related diseases, growing incidence of burn related injuries, and rising prevalence of diabetes.

A more than 150-page report is developed to help in your business decisions.

Topical Drug Delivery by Segment

The study includes a forecast for the global topical drug delivery by product, route of administration, end use industry, technology, and region.

Topical Drug Delivery Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Semi-Solid Formulations
  • Liquid Formulations
  • Solid Formulations
  • Transdermal Products

Topical Drug Delivery Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:

  • Dermal Drug Delivery
  • Ophthalmic Drug Delivery
  • Rectal Drug Delivery
  • Vaginal Drug Delivery
  • Nasal Drug Delivery

Topical Drug Delivery Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

  • Home Care Settings
  • Hospitals & Clinics
  • Burn Centers
  • Others

Topical Drug Delivery Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Topical Drug Delivery Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies topical drug delivery companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the topical drug delivery companies profiled in this report include-

  • Glenmark Pharmaceuticals
  • Galderma
  • Johnson & Johnson
  • GlaxoSmithkline
  • Bausch Health
  • Hisamitsu Pharmaceuticals
  • Cipla
  • Bayer
  • Viatris
  • 3M

Topical Drug Delivery Market Insights

Lucintel forecast that semi-solid formulations is expected to witness highest growth over the forecast period due to its flexibility in delivering different pharmacological compounds and ease of use.

Home care settings will remain the largest segment due to increasing need for affordable and convenient topical drug delivery services in this setting.

North America is expected to witness highest growth over the forecast period due to growing number of smokers, high demand for self-administered medications, and presence of key pharmaceutical players in the region.

Features of the Global Topical Drug Delivery Market

Market Size Estimates: Topical drug delivery market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Topical drug delivery market size by product, route of administration, end use industry, and region. in terms of value ($B).

Regional Analysis: Topical drug delivery market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, route of administrations, end use industries, and region.s for the topical drug delivery market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the topical drug delivery market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the topical drug delivery market size?

Answer: The global topical drug delivery market is expected to reach an estimated $396.6 billion by 2030.

Q.2. What is the growth forecast for topical drug delivery market?

Answer: The global topical drug delivery market is expected to grow with a CAGR of 8.5% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the topical drug delivery market?

Answer: The major drivers for this market are increasing frequency of skin related diseases, growing incidence of burn related injuries, and rising prevalence of diabetes.

Q.4. What are the major segments for topical drug delivery market?

Answer: The future of the topical drug delivery market looks promising with opportunities in the home care settings, hospitals & clinics, and burn centers markets.

Q.5. Who are the key topical drug delivery market companies?

Answer: Some of the key topical drug delivery companies are as follows:

  • Glenmark Pharmaceuticals
  • Galderma
  • Johnson & Johnson
  • GlaxoSmithkline
  • Bausch Health
  • Hisamitsu Pharmaceuticals
  • Cipla
  • Bayer
  • Viatris
  • 3M

Q.6. Which topical drug delivery market segment will be the largest in future?

Answer: Lucintel forecast that semi-solid formulations is expected to witness highest growth over the forecast period due to its flexibility in delivering different pharmacological compounds and ease of use.

Q.7. In topical drug delivery market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to growing number of smokers, high demand for self-administered medications, and presence of key pharmaceutical players in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the topical drug delivery market by product (semi-solid formulations, liquid formulations, solid formulations, and transdermal products), route of administration (dermal drug delivery, ophthalmic drug delivery, rectal drug delivery, vaginal drug delivery, and nasal drug delivery), end use industry (home care settings, hospitals & clinics, burn centers, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Topical Drug Delivery Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Topical Drug Delivery Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Topical Drug Delivery Market by Product
    • 3.3.1: Semi-Solid Formulations
    • 3.3.2: Liquid Formulations
    • 3.3.3: Solid Formulations
    • 3.3.4: Transdermal Products
  • 3.4: Global Topical Drug Delivery Market by Route of Administration
    • 3.4.1: Dermal Drug Delivery
    • 3.4.2: Ophthalmic Drug Delivery
    • 3.4.3: Rectal Drug Delivery
    • 3.4.4: Vaginal Drug Delivery
    • 3.4.5: Nasal Drug Delivery
  • 3.5: Global Topical Drug Delivery Market by End Use Industry
    • 3.5.1: Home Care Settings
    • 3.5.2: Hospitals & Clinics
    • 3.5.3: Burn Centers
    • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Topical Drug Delivery Market by Region
  • 4.2: North American Topical Drug Delivery Market
    • 4.2.1: North American Topical Drug Delivery Market by Product: Semi-Solid Formulations, Liquid Formulations, Solid Formulations, and Transdermal Products
    • 4.2.2: North American Topical Drug Delivery Market by End Use Industry: Home Care Settings, Hospitals & Clinics, Burn Centers, and Others
  • 4.3: European Topical Drug Delivery Market
    • 4.3.1: European Topical Drug Delivery Market by Product: Semi-Solid Formulations, Liquid Formulations, Solid Formulations, and Transdermal Products
    • 4.3.2: European Topical Drug Delivery Market by End Use Industry: Home Care Settings, Hospitals & Clinics, Burn Centers, and Others
  • 4.4: APAC Topical Drug Delivery Market
    • 4.4.1: APAC Topical Drug Delivery Market by Product:Semi-Solid Formulations, Liquid Formulations, Solid Formulations, and Transdermal Products
    • 4.4.2: APAC Topical Drug Delivery Market by End Use Industry: Home Care Settings, Hospitals & Clinics, Burn Centers, and Others
  • 4.5: ROW Topical Drug Delivery Market
    • 4.5.1: ROW Topical Drug Delivery Market by Product:Semi-Solid Formulations, Liquid Formulations, Solid Formulations, and Transdermal Products
    • 4.5.2: ROW Topical Drug Delivery Market by End Use Industry: Home Care Settings, Hospitals & Clinics, Burn Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Topical Drug Delivery Market by Product
    • 6.1.2: Growth Opportunities for the Global Topical Drug Delivery Market by Route of Administration
    • 6.1.3: Growth Opportunities for the Global Topical Drug Delivery Market by End Use Industry
    • 6.1.4: Growth Opportunities for the Global Topical Drug Delivery Market Region
  • 6.2: Emerging Trends in the Global Topical Drug Delivery Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Topical Drug Delivery Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Topical Drug Delivery Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Glenmark Pharmaceuticals
  • 7.2: Galderma
  • 7.3: Johnson & Johnson
  • 7.4: GlaxoSmithkline
  • 7.5: Bausch Health
  • 7.6: Hisamitsu Pharmaceuticals
  • 7.7: Cipla
  • 7.8: Bayer
  • 7.9: Viatris
  • 7.10: 3M